Department of Obstetrics and Gynecology, Teine Keijinkai Hospital, Sapporo, Japan; Department of Obstetrics and Gynecology, Yokohama City University, Yokohama, Japan.
Department of Obstetrics and Gynecology, Teine Keijinkai Hospital, Sapporo, Japan.
J Minim Invasive Gynecol. 2018 Mar-Apr;25(3):507-513. doi: 10.1016/j.jmig.2017.08.660. Epub 2017 Oct 24.
To evaluate a new magnetic resonance imaging (MRI) grading system for preoperative differentiation between benign and variant-type uterine leiomyomas including smooth muscle tumors of uncertain malignant potential (STUMPs).
Retrospective analysis (Canadian Task Force classification III).
Teaching hospital (Teine Keijinkai Hospital).
Three-hundred thirteen patient medical records were retrospectively reviewed if treated for uterine myomas and diagnosed with variant type leiomyomas or STUMPs (n = 27) or benign, typical leiomyomas (n = 286) and treated between January 2012 and December 2014.
Uterine myoma classifications using MRI findings according to a 5-grade system (grades I-V) based on 3 elements.
Uterine myoma MRI classifications were based on 3 elements: T2-weighted imaging (high or low), diffusion-weighted imaging (high or low), and apparent diffusion coefficient values (high or low; apparent diffusion coefficient < 1.5 × 10 mm/sec was considered low). Grades I to II were designated as typical or benign leiomyomas, grade III as degenerated leiomyomas, and grades IV to V as variant type leiomyomas or STUMPs. Accuracy levels were 98.9%, 100%, 94.3%, 58.8%, and 41.9% for grades I through V lesions, respectively. The grades were divided into 2 groups to discriminate benign leiomyomas and STUMPs (grades I-III were considered negative and grades IV-V positive). Grades IV to V scored 85.2% for sensitivity, 91.3% for specificity, 47.9% positive predictive value, 98.5% negative predictive value, a 9.745 positive likelihood ratio, and a .162 negative likelihood ratio.
This novel MRI grading system for uterine myomas may be beneficial in differentiating benign leiomyomas from STUMPs or variant type leiomyomas and could be a future effective presurgical assessment tool.
评估一种新的磁共振成像(MRI)分级系统,用于术前区分良性和变异型子宫平滑肌瘤,包括平滑肌肿瘤的恶性潜能不确定(STUMPs)。
回顾性分析(加拿大任务组分类 III)。
教学医院(天神会医院)。
如果因子宫平滑肌瘤接受治疗且诊断为变异型平滑肌瘤或 STUMPs(n=27)或良性、典型平滑肌瘤(n=286),则回顾性分析 2012 年 1 月至 2014 年 12 月期间的 313 例患者的病历。
根据基于 3 个要素的 5 级系统(I-V 级)对子宫平滑肌瘤进行 MRI 分类。
子宫平滑肌瘤 MRI 分类基于 3 个要素:T2 加权成像(高或低)、弥散加权成像(高或低)和表观弥散系数值(高或低;表观弥散系数<1.5×10mm/sec 被认为是低)。I 级至 II 级被指定为典型或良性平滑肌瘤,III 级为退行性平滑肌瘤,IV 级至 V 级为变异型平滑肌瘤或 STUMPs。I 至 V 级病变的准确率分别为 98.9%、100%、94.3%、58.8%和 41.9%。将这些等级分为 2 组以区分良性平滑肌瘤和 STUMPs(I-III 级为阴性,IV-V 级为阳性)。IV 级至 V 级的敏感性为 85.2%,特异性为 91.3%,阳性预测值为 47.9%,阴性预测值为 98.5%,阳性似然比为 9.745,阴性似然比为 0.162。
这种新的子宫平滑肌瘤 MRI 分级系统有助于区分良性平滑肌瘤和 STUMPs 或变异型平滑肌瘤,可能成为未来有效的术前评估工具。